{
    "startDate": "2019-01-01",
    "endDate": "2019-03-31",
    "year": "2019",
    "quarter": "Q1",
    "symbol": "TROV",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents\u2014Beginning of period",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 11330079
            },
            {
                "label": "Accounts receivable and unbilled receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 115676
            },
            {
                "label": "Prepaid expenses",
                "concept": "PrepaidExpenseCurrent",
                "unit": "usd",
                "value": 890725
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 12336480
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 293361
            },
            {
                "label": "Decrease in operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 1816286
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 87073
            },
            {
                "label": "Assets:",
                "concept": "Assets",
                "unit": "usd",
                "value": 14533200
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 466747
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2021737
            },
            {
                "label": "Operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 796246
            },
            {
                "label": "Deferred rent, current portion",
                "concept": "DeferredRentCreditCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3284730
            },
            {
                "label": "Derivative financial instruments\u2014warrants",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 42076
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 1520213
            },
            {
                "label": "Deferred rent, net of current portion",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Liabilities:",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4847019
            },
            {
                "label": "Commitments and Contingencies Disclosure [Abstract]",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value, 20,000,000 shares authorized; 277,100 designated as Series A Convertible Preferred Stock; 60,600 shares outstanding at March 31, 2019 and December 31, 2018 with liquidation preference of $606,000 at March 31, 2019 and December 31, 2018; 200,000 designated as Series C Convertible Preferred Stock; 200,000 and 0 shares outstanding at March 31, 2019 and December 31, 2018, respectively",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 260
            },
            {
                "label": "Common stock, $0.0001 par value, 150,000,000 shares authorized; 4,525,354 and 3,831,880 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 7906
            },
            {
                "label": "Additional Paid-In Capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 207652843
            },
            {
                "label": "Service receivables",
                "concept": "trov:Servicereceivable",
                "unit": "usd",
                "value": 1604513
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -196370315
            },
            {
                "label": "Stockholders' Equity Note [Abstract]",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 9686181
            },
            {
                "label": "Liabilities and Stockholders\u2019 Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 14533200
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3904771
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 45911
            },
            {
                "label": "Equity Award [Domain]",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 200067
            },
            {
                "label": "Deferred rent",
                "concept": "IncreaseDecreaseInDeferredCharges",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": -9761
            },
            {
                "label": "Release of clinical trial funding commitment",
                "concept": "trov:Releaseofclinicaltrialfundingcommitmentforservicesreceived",
                "unit": "usd",
                "value": 70487
            },
            {
                "label": "Decrease in other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -15725
            },
            {
                "label": "Decrease in accounts receivable and unbilled receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -52079
            },
            {
                "label": "Decrease in prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidExpense",
                "unit": "usd",
                "value": -179691
            },
            {
                "label": "Decrease in operating lease right-of-use assets",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": -154058
            },
            {
                "label": "Increase in accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 3635
            },
            {
                "label": "Decrease in operating lease liabilities",
                "concept": "trov:IncreaseDecreaseInOperatingLeaseLiability",
                "unit": "usd",
                "value": -186689
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -3360046
            },
            {
                "label": "Capital expenditures",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 5274
            },
            {
                "label": "Investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -5274
            },
            {
                "label": "Costs related to the clinical trial funding commitment",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": -40000
            },
            {
                "label": "Proceeds from exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": 3282266
            },
            {
                "label": "Repayments of equipment line of credit",
                "concept": "RepaymentsOfLongTermLinesOfCredit",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 3242266
            },
            {
                "label": "Net change in cash and cash equivalents",
                "concept": "NetCashProvidedByUsedInContinuingOperations",
                "unit": "usd",
                "value": -123054
            },
            {
                "label": "Cash paid for taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 800
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "trov:PreferredStockDividendAccrued",
                "unit": "usd",
                "value": 6060
            },
            {
                "label": "Deemed dividend recognized for beneficial conversion features of Series C Convertible Preferred Stock issuance",
                "concept": "trov:DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock",
                "unit": "usd",
                "value": 268269
            },
            {
                "label": "Common stock, preferred stock and warrants issued in connection with clinical trial funding commitment",
                "concept": "trov:Commonstockpreferredstockandwarrantsissuedinconnectionwithclinicaltrialfundingcommitment",
                "unit": "usd",
                "value": 1675000
            }
        ],
        "ic": [
            {
                "label": "Royalties",
                "concept": "RoyaltyRevenue",
                "unit": "usd",
                "value": 62021
            },
            {
                "label": "Services and other",
                "concept": "SalesRevenueServicesNet",
                "unit": "usd",
                "value": 99937
            },
            {
                "label": "Total revenues",
                "concept": "SalesRevenueNet",
                "unit": "usd",
                "value": 161958
            },
            {
                "label": "Cost of revenues",
                "concept": "CostOfRevenue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 2648599
            },
            {
                "label": "Selling, general and administrative expense",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1475122
            },
            {
                "label": "Costs and expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 4123721
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -3961763
            },
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 64743
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Change in fair value of derivative financial instruments\u2014warrants",
                "concept": "UnrealizedGainLossOnDerivatives",
                "unit": "usd",
                "value": -9761
            },
            {
                "label": "Other income, net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 2010
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3904771
            },
            {
                "label": "Preferred stock dividend payable on Series A Convertible Preferred Stock",
                "concept": "PreferredStockDividendsIncomeStatementImpact",
                "unit": "usd",
                "value": 6060
            },
            {
                "label": "Deemed dividend recognized for beneficial conversion features of Series C Convertible Preferred Stock issuance",
                "concept": "trov:DeemedDividendRelatedToBeneficialConversionFeatureOfPreferredStock",
                "unit": "usd",
                "value": 268269
            },
            {
                "label": "Net loss attributable to common stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -4179100
            },
            {
                "label": "Net loss per common share - basic (in USD per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -1.02
            },
            {
                "label": "Net loss per common share - diluted (in USD per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -1.02
            },
            {
                "label": "Weighted-average shares outstanding \u2014 basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 4086561
            },
            {
                "label": "Weighted-average shares outstanding \u2014 diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 4086561
            }
        ]
    }
}